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A B S T R A C T
Background: The Gait Profile Score (GPS) provides a composite measure of the quality of joint movement during 
walking, but the relationship between this measure and metabolic cost, temporal (e.g. walking speed) and spatial 
(e.g. stride length) parameters in stroke survivors has not been reported. 
Research Question: The aims of this study were to compare the GPS (paretic, non-paretic, and overall score) of 
young stroke survivors to the healthy able-bodied control and determine the relationship between the GPS and 
metabolic cost, temporal (walking speed, stance time asymmetry) and spatial (stride length, stride width, step 
length asymmetry) parameters in young stroke survivors to understand whether the quality of walking affects 
walking performance in stroke survivors. 
Methods: Thirty-nine young stroke survivors aged between 18 and 65years and 15 healthy age-matched able- 
bodied controls were recruited from six hospital sites in Wales, UK. Joint range of motion at the pelvis, hip, knee 
and ankle, and temporal and spatial parameters were measured during walking on level ground at self-selected 
speed with calculation of the Gait Variable Score and then the GPS. 
Results: GPS for the paretic leg (9.40◦ (8.60–10.21) p < 0.001), non-paretic leg (11.42◦ (10.20–12.63) p < 0.001) 
and overall score (11.18◦ (10.26–12.09) p < 0.001)) for stroke survivors were significantly higher than the 
control (4.25◦ (3.40–5.10), 5.92◦ (5.11 (6.73)). All parameters with the exception of step length symmetry ratio 
correlated moderate to highly with the GPS for the paretic, non-paretic, and/or overall score (ρ = <− 0.732 (p <
0.001)). 
Significance: The quality of joint movement during walking measured via the GPS is directly related to the speed 
and efficiency of walking, temporal (stance time symmetry) and spatial (stride length, stride width) parameters 
in young stroke survivors.   
1. Introduction
Adults who have had a stroke walk slower and less efficiently with
distinct differences and/or asymmetry in temporal (e.g., stance time), 
spatial (e.g., stride length, step length), joint kinematic and kinetic pa-
rameters of the paretic and non-paretic limbs when compared to healthy 
able-bodied controls [1–12]. Muscle weakness and/or spasticity, 
impaired balance, and increased reluctance to bear weight on the paretic 
limb can cause abnormally increased or decreased joint range of motion, 
reduced joint moments and decreased power absorption and/or gener-
ation by muscles groups of the lower limb (e.g., calf muscles) [3,8–12]. 
Whilst gait kinematics and kinetics provide in-depth detail regarding 
the biomechanical function of the lower limb during walking, inter-
preting this data clinically can be challenging [13]. It also generates vast 
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amount of data and parameters which are important to assess [14], but 
identifying which and how these parameters are related to walking 
performance parameters such as metabolic cost and walking speed is 
difficult. 
In response to this, several researchers have developed gait assess-
ment measures that provide an overall and composite representation of 
gait kinematics and the quality of walking which can be easily inter-
preted in a clinical setting. These include the Gait Deviation Index [15], 
Gillete Gait Index [16] and the Gait Profile Score (GPS) [13]. 
The GPS has gained considerable popularity and has been widely 
reported in a variety of clinical populations due to its simplicity and 
good reliability [13,17–20]. It is derived by calculating the root mean 
square difference between the angular trajectories of a participant 
compared to a reference healthy able-bodied sample with no pathology 
[13]. The GPS provides an indication of the quality of movement and 
because it is measured in degrees it offers a more direct clinical inter-
pretation for what the score outcome means (i.e., enabling a direct 
comparison to a healthy-able-bodied individual) [13,18]. A GPS of be-
tween 5◦ and 6◦ has been routinely reported for healthy able-bodied 
control population [13,18,21,22], therefore inferring scores above this 
indicate poor quality of walking or an abnormal gait pattern. 
Only three studies have reported the GPS in stroke survivors [19,20, 
22]. Fukuchi et al. [22] used the GPS to develop a specific GPS sensitive 
to walking speed and Devetak et al. [19] tested its intra and inter-session 
reliability. Bigoni et al. [20] reported that the GPS was fairly correlated 
to clinical measures such as the 10-metre walk test, functional ambu-
lation category and a good correlation to the Berg Balance Scale. No 
study has investigated the relationship between the GPS and the effi-
ciency of walking, temporal, and spatial parameters, and yet these are 
commonly altered post-stroke which we can hypothesise are caused by 
abnormal joint kinematics. 
There are relatively few gait studies in young stroke survivors, and 
none have measured the GPS in young stroke survivors. Understanding 
how the quality and quantity of walking is affected post-stroke and its 
relationship to walking speed and metabolic cost may help better inform 
rehabilitation programmes for young stroke survivors [1]. As young 
stroke survivors are less likely to be affected by age-related changes 
associated with bone degeneration and muscle weakness, capturing the 
GPS in young stroke survivors may help to determine the true effect of a 
stroke on this gait measure without the confounding factor of age. 
The aims of this study were to: 1. Compare the GPS (paretic, non- 
paretic and overall score) of young stroke survivors to the GPS of the 
healthy able-bodied control, and 2. Determine the relationship between 
the GPS scores and metabolic cost, temporal (walking speed, stance time 
asymmetry) and spatial (stride length, stride width, step length asym-
metry) parameters in young stroke survivors. We hypothesise that young 
stroke survivors will walk with a higher GPS than the control and that 
the higher the GPS the slower the walking speed and less efficient young 
stroke survivors are at walking, suggesting a strong relationship between 
these variables. 
2. Methods
This study was approved by the NHS Research Ethics Committee
(Wales Regional Ethics Committee 6 18/WA/0265) and Health Research 
Authority (UK) and Manchester Metropolitan University Research Ethics 
Committee. Informed written consent to take part in this study was 
obtained from each participant and thirty-nine individuals aged be-
tween 18 and 65 years were recruited and agreed to participate from six 
health boards in Wales, UK between September 2018 and October 2018. 
Inclusion criteria for stroke participants were 18–65 years of age, hae-
morrhage or infarct stroke within the last t3-years that is evident from a 
computerised tomography (CT) scan, singular lesion that occurred in 
one hemisphere in the brain and able to walk continuously for at least 
three minutes. Stroke participants with multiple lesions in different 
hemispheres in the brain or a lesion in the brainstem were excluded. 
Participants who had a stroke but were also diagnosed with a disease 
that was the predominant health concern that limited their ability to 
walk, were also excluded from this study. 
Fifteen control participants were recruited and agreed to participate. 
Inclusion criteria was no history of stroke, neurological, musculoskel-
etal, cardiovascular, auto immune, or respiratory disease. Very physi-
cally active (e.g., elite athletes) individuals, or participants who smoke 
or have smoked in the past were excluded from this study. 
2.1. Outcome measures 
2.1.1. Demographic data 
Demographic data included age, body mass, height, time since 
stroke, type of stroke, and whether the right or left side was predomi-
nantly affected by the stroke was used to determine the paretic and non- 
paretic limb. A summary of demographic measures are presented in the s 
manuscript, individual and other demographic measures are available in 
Supplementary Data Table 3 and here [1]. 
3. Methods
3.1. Joint kinematics
An eight-camera optoelectronic motion capture system (Oqus, 
Qualisys motion capture system, Qualisys, Sweden) was placed around a 
15 m walkway with four Kistler force plates embedded within a 
walkway to capture three-dimensional walking biomechanics. Retro- 
reflective markers were placed on anatomical landmarks to define 
joint centres and body segments using the marker set previously 
described in previous stroke research [23]. Please see Table 1 (Supple-
mentary data). Motion analysis data was collected at 120 Hz and ground 
reaction forces at 1200 Hz. A static standing trial was recorded for each 
participant to calculate a participant-specific calculation of the location 
of joint centres and then participants completed seven walking trials of 
approximately 5 m in length. The average of these walking trials was 
then used per joint to calculate the GPS. 
Data were digitised in Qualisys Track Manager, Qualisys, Sweden 
and then exported for modelling and analysis within Visual 3D (C-Mo-
tion, Rochelle, USA). A model specific to the height and body mass of 
each participant was created. The inertial parameters were calculated 
for the pelvis, hip, knee, ankle, and foot using inverse dynamics. This 
allows specific constraints to be applied at the joints of the virtual model 
so to limit rotation and or translation. The pelvis permitted six degrees of 
freedom, but only sagittal, coronal, and transverse plane rotation was 
permitted at all other joints. Gait events (initial contact and foot off) 
were defined from contact with the force plates. Visual 3D was used to 
calculate and extract wave form angles for the pelvis, hip, knee, ankle, 
and foot for each plane of motion. 
3.2. Calculation of GPS 
The GPS [13] was calculated from the gait variable score which is 
calculated by the root mean square difference between joint angles of 
each participant and the average of the healthy able-bodied participants 
during the gait cycle. There are fifteen gait variable scores. Four from the 
sagittal plane (pelvis anterior/posterior tilt, hip flexion/extension, knee 
flexion/extension, ankle dorsiflexion/plantarflexion), two from the 
coronal plane (pelvis up/down, hip adduction/abduction) and three 
from the transverse plane (pelvis internal/external, hip internal/-
external and foot progression) for each leg and only pelvis kinematics 
from the paretic/left leg were used. 
3.3. Temporal and spatial parameters 
Gait events (initial contact and foot off) were defined from contact 
with force plates and used to calculate temporal and spatial parameters. 
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Temporal parameters included walking speed, stance time and spatial 
parameters included stride length, stride width, and step length. Sym-
metry ratios for step length and stance time were calculated using the 
recommended calculation by other studies [1,4]. See Supplementary 
Table 2 for description of temporal and spatial parameters calculation. 
3.4. Metabolic cost 
To capture metabolic energy expenditure during walking, partici-
pants were fitted with a gas analyser (Cortex Metalyser, Biophysik) 
which measures oxygen consumption. All participants walked at their 
self-selected speed for three minutes up and down a 15 m long runway 
with timing gates situated 5 m from either end of the runway to measure 
walking speed. The last minute of oxygen consumption data from each 
participant was used for analysis. Oxygen consumption underwent 
normalisation to body mass and to calculate the metabolic cost of 
walking, which is a measure of efficiency, oxygen consumption was 
divided by walking speed, which indicates the millilitres of oxygen up-
take required per kilogram of bodyweight to cover a metre of ground. 
3.5. Statistical analysis 
Statistical analysis was conducted using SPSS Version 24. All data 
were checked for normality using the Shapiro-Wilko test and measures 
of skewness and kurtosis. Mean and 95% confidence interval were 
calculated for each parameter. The GPS for the paretic, non-paretic and 
overall score, metabolic cost, temporal, and spatial parameters of young 
stroke survivors were compared to the healthy able-bodied control (left 
leg score was compared to paretic and non-paretic leg) using Mann 
Whitney U tests with a Bonferroni correction. The GPS of the paretic leg 
was compared to the non-paretic leg for young stroke survivors using a 
Mann Whitney U test with Bonferroni correction. The GPS for the 
paretic, non-paretic and overall score was correlated to metabolic cost, 
temporal and spatial parameters using a Spearman’s rho correlation. 
4. Results
4.1. Demographic data
Young stroke survivors were thirty-two male and seven females, aged 
49.60years (45.98–53.22)) and time since stroke 12.9 months 
(9.2–16.6)) (Table 1). All with confirmed stroke diagnosis by CT scan (n 
= 10 haemorrhage, n = 29 ischaemic), the paretic limb was the right for 
n = 20 and left for n = 19 participants. Supplementary Data Table 3 
provides demographic and neurological data for stroke participants. 
Control participants were seven male and eight females (Table 1). 
4.1.1. Comparison of the GPS, temporal and spatial parameters and 
metabolic cost of young stroke survivors compared to the healthy able-bodied 
control 
GPS for the paretic leg (9.40◦ (8.60–10.21) p < 0.001), non-paretic 
leg (11.42◦ (10.20–12.63) p < 0.001) and overall score (11.18◦
(10.26–12.09) p < 0.001)) were significantly higher than the control 
(4.25◦ (3.40–5.10), 5.92◦ (5.11 (6.73)) (Table 2). The GPS of the paretic 
leg was significantly less than the than the non-paretic leg (p = 0.010). 
Young stroke survivors walked significantly slower and less effi-
ciently (0.81 m/s (0.69–0.93) p < 0.001, 0.29 ml/kg/m (0.24–0.34) p <
0.001), compared to the control (1.42 m/s (1.33–1.51), 0.15 ml/kg/m 
(0.14–0.15)) (Table 2). Stride length (0.89 m (0.77–1.00) p = <0.001) 
and width 0.26 m ((0.18–0.34) p < 0.001) were significantly shorter and 
wider for young stroke survivors compared to the control (1.33 m 
(1.24–1.41), 0.12 m (0.11–0.14)) (Table 1). Step length symmetry ratio 
was greater (1.25 (0.89–1.62) p < 0.001)) and stance time symmetry 
ratio (0.95 (0.91–0.99) p < 0.001)) less for young stroke survivors 
compared to the control (0.93 (0.87–0.98), 1.01 (0.96–1.05)) (Table 2). 
Table 1 
Presents mean and 95% confidence interval for participant demographics. n/a: 
not applicable.   
Stroke (n ¼ 39) Control (n ¼ 15) 
Age (years) 49.60 (45.98–53.22) 44.53 (36.17–52.88) 
Male/Female n = 32/n = 7 n = 7/n = 8 
Body mass (kg) 93.25 (84.86–101.64) 74.98 (67.78–82.18) 
Height (m) 1.71 (1.65–1.77) 1.73 (1.69–1.78) 
Time since stroke (months) 12.86 (9.17–16.56) n/a  
Table 2 
Presents mean and 95% confidence interval for participant demographics, 
walking speed, metabolic cost, GPS (paretic, non-paretic limbs and overall 
score), stride length, stride width, step length asymmetry and stance time 
asymmetry for young stroke survivors compared to controls. Left leg was used 
for control participants to compare to GPS paretic, non-paretic and overall score.   
Stroke (n ¼ 39) Control (n ¼ 15) 
Walking Speed (m/s) 0.81 (0.69–0.93) 1.42 (1.33–1.51) 
p < 0.001 
Metabolic Cost (ml/kg/m) 0.29 (0.24–0.34) 0.15 (0.14–0.15) 
p < 0.001 
GPS Paretic leg (◦) (Left leg control) 9.40 (8.60–10.21) 4.25 (3.40–5.10) 
p 0.001 





p < 0.001 




Stride Length (m) 0.89 (0.77–1.00) 1.33 (1.24–1.41) 
P < 0.001 
Stride Width (m) 0.26 (0.18–0.34) 0.12 (0.11–0.14) 
p < 0.001 
Step Length asymmetry 1.25 (0.89–1.62) 0.93 (0.87–0.98) 
p < 0.001 
Stance time asymmetry 0.95 (0.91–0.99) 1.01 (0.96–1.05) 
p < 0.001  
Table 3 
presents the Gait Variable Score for the paretic, non-paretic and control limbs for 
each parameter used to calculate the Gait Profile Score. No formal statistical 
analysis was conducted to compare between groups as multiple comparisons 
would be required and the overall gait profile score should be used for formal 
between group analysis.  
Parameter Stroke (n ¼ 39) Control (n ¼ 15) 
Gait Variable 
Score Paretic leg 
Gait Variable Score 
Non-paretic leg 
Gait Variable 




6.13 (5.01–7.25) 6.83 (5.34–8.32) 3.95 (2.35–5.55) 





20.37 (17.13–23.60) 4.33 (3.49–5.17) 
Ankle Dor/ 
Pla 
9.14 (8.02–10.26) 11.15 (9.36–12.93) 4.60 (2.99–6.22) 
Pelvis Up/ 
Dn 
4.39 (3.73–5.06) 4.76 (4.12–5.40) 1.95 (1.37–2.53) 
Hip Add/ 
Abd 
4.82 (3.99–5.65) 5.00 (4.21–5.80) 3.26 (2.37–4.15) 
Pelvic Int/ 
Ext 
5.14 (3.93–6.35) 5.69 (3.91–7.47) 2.48 (1.80–3.17) 
Hip Int/Ext 8.97 (7.16–10.78) 6.50 (5.50–7.50) 4.30 (3.14–5.45) 
Foot Int/Ext 10.13 (8.19–12.06) 12.27 (9.37–15.18) 4.31 (2.86–5.75) 
GPS 9.40 (8.60–10.21) 11.42 (10.20–12.63) 4.25 (3.40–5.10) 
GPS overall 
score 
11.18 (10.26–12.09) 5.92 (5.11–6.73)  
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4.1.2. Relationship between the GPS, temporal and spatial parameters, and 
metabolic cost in young stroke survivors 
All gait parameters with the exception of step length symmetry ratio 
correlated moderate to highly to the GPS (Table 3, Fig. 1). Higher cor-
relations were observed between the GPS of the paretic leg and the 
overall score than the non-paretic leg across all parameters. Walking 
speed correlated negatively and moderately to the GPS for the paretic 
leg (ρ = − 0.543 (p < 0.001) and overall score (ρ = − 0.397 (p = 0.012)), 
whilst metabolic cost correlated positively and strongly to the GPS for 
the paretic (ρ = 0.644 (p < 0.001)) and overall score (ρ = 0.472 (p =
0.002) (Table 3, Fig. 1). Stride length correlated negatively and strongly 
to the GPS for the paretic (ρ = − 0.732 (p < 0.001)), moderately to the 
non-paretic (ρ = − 0.418 (p = 0.008)) and overall score (ρ = − 0.572 (p 
< 0.001)). Similarly, stride width correlated with the GPS positively and 
moderately for the paretic leg (ρ = 0.543 (p = 0.001), and the overall 
score (ρ = 0.408 (p = 0.01) (Table 3, Fig. 1). Stance time symmetry ratio 
was negatively and moderately correlated, but only for the non-paretic 
leg (ρ = − 0.499 (p = 0.001)) and overall score (ρ = − 0.454 (p =
0.004)) (Table 3, Fig. 1). Table 4. 
5. Discussion
This study reports for the first time a measure of the GPS in young
stroke survivors. The GPS correlated against key gait variables and 
shows that a stroke not only affects the magnitude of joint movement (as 
previously reported [8,12,24], but also the quality of movement 
measured via the GPS and is related to the speed and efficiency of 
walking, temporal (stance time symmetry) and spatial (stride length, 
stride width) parameters in young stroke survivors. It can be challenging 
to choose which individual parameters may be most useful to measure 
gait performance, but the GPS provides a composite measure of the 
quality of gait which correlates to other easily measured walking per-
formance variables. 
The GPS correlated moderately with nearly all gait parameters, 
except for step length symmetry ratio. Moderate and strong correlations 
were recorded between the GPS of the paretic leg and overall score with 
walking speed, metabolic cost, stride length and stride width. The results 
indicate that with a higher GPS, walking speed will decrease, metabolic 
cost increases, stride length shortens, and stride width widens. The 
Fig. 1. Scatter plot of the GPS for the paretic leg (red dots), non-paretic leg (blue leg) and overall score (green dots) correlated to: A walking speed, B. metabolic cost, 
C. stride length, D. stride width, E. step length symmetry ratio, F. stance time symmetry ratio for young stroke survivors. Red dotted line represents trendline for
paretic leg, blue dotted line represents trendline for non-paretic leg, green dotted line represents trendline for overall score.
H.L. Jarvis et al.
233
results also suggest that the quality of joint kinematics of the non-paretic 
limb is more affected than the paretic limb which was also reported by 
others [19]. We can hypothesise that this is due to compensation stra-
tegies by the non-paretic limb to accommodate for the reduced function 
of the paretic limb. 
The negative correlation between stance time symmetry ratio and 
the GPS for the non-paretic leg and overall score further supports the 
notion that due to muscle weakness or spasticity, stroke survivors are 
reluctant to bear weight on to the paretic limb [1]. Therefore, rehabil-
itation strategies should focus on promoting weight acceptance by the 
paretic limb to improve the quantity and quality of gait post-stroke. This 
could include specific strengthening of the knee and hip extensors, knee 
flexors and ankle plantarflexors in a functionally relevant manner/si-
tuation to promote weight acceptance during gait. 
This is the first time the GPS has been reported in young stroke 
survivors. Previous research has focused on older adults. When 
compared to other studies, the GPS for participants in this study are less 
than Devetak et al. [19] with 13.9 (SD=2.4), but greater than Fukuchi 
et al. [22] 8.0 (SD=3.1). A lower GPS reported by Fukuchi et al. [22] 
suggests that the quality of walking by participants in that study is better 
than ours and Devetak et al. [19] but this is likely due to the level of 
neurological impairment. Nor this study or those studies have accounted 
for the level of neurological impairment (defined by CT scan or MRI) 
when interpreting the GPS and is a limitation of our and those studies. 
The clinical implications of this research will be to provide results to 
an already limited evidence base on how a stroke affects the quality of 
gait, but in particular it is the first study to report this in young adults 
who have had a stroke. The incidence of stroke in young adults has 
increased by 40% in the past decade [25], but there is little research 
targeted to the young population, therefore our work is key to bettering 
an understanding of gait in stroke, and designing rehabilitation pro-
grammes to improve walking performance in young stroke. 
The narrow 95% confidence intervals for the GPS indicate marginal 
inter-participant variation, but other studies have suggested a wide 
range in temporal, spatial, joint kinematic and kinetic parameters [1,5, 
8,11,12,26]. This may well be due to the number of parameters used in 
the GPS (n = 15) which could mean that high gait variables score for 
some joints or some participants are cancelled out by low scores in 
others when calculating the GPS. Therefore, the GPS might not reflect 
the range in the quality of walking post-stroke if there is a high 
inter-participant variation within a sample which there often is when 
measuring gait in stroke survivors. This is potentially a limitation of the 
GPS, but more likely reflective of the variability within our sample with 
regards to variation in age, time since stroke, level of disability, type of, 
location and cause of stroke which all affect gait post-stroke. Although 
our participant cohort is larger than other studies reporting the GPS in 
stroke patients [19,22] and other conditions [21,27] it is still relatively 
small when compared to studies reporting this data in other patient 
groups [13]. 
Other limitations of our study include the small sample size of the 
able-bodied control group (n = 15), in the stroke group the ratio be-
tween male and female participants was uneven with n = 32 (male) and 
n = 7 (female) while for the control it was relatively even at n = 7 
(male) and n = 8 (female). Other studies [28] have reported differences 
in joint kinematics between males and females so this may have caused 
some differences between our stroke group and control. GPS uses lower 
limb data only and therefore whilst it provides a measure of lower limb 
quality of movement during walking, it does not include the effect of the 
movement of the torso, head and arms on lower limb movement. 
Although we captured which side was paretic or non-paretic, we did not 
capture which was the dominant side as this may also affect walking 
performance if the dominant side is affected following a stroke 
compared to non-dominant side. 
6. Conclusion
The GPS is higher in young stroke survivors compared to the able- 
bodied control. This study reports that the GPS is strongly related to 
the efficiency of walking, temporal, and spatial parameters. This sug-
gests that it is not only the magnitude of joint movement that is affected 
post-stroke, but also the quality of that movement which may help to 
inform rehabilitation for stroke survivors. 
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